Fig. 2From: Artemisinin-naphthoquine plus lower-dose primaquine to treat and prevent recurrence of Plasmodium vivax malaria: an open-label randomized and non-inferiority trialTime and numbers of recurrence in each treatment regimen. ANPQ3 denotes artemisinin-naphthoquine plus primaquine for 3Â days; CQPQ14 denotes chloroquine plus primaquine for 14Â daysBack to article page